Complicated Intra-abdominal Infection

11 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(8)

Drug	Company
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
emblaveo	AbbVie Inc. (ABBV)
xerava	LA JOLLA PHARMACEUTICAL CO (LJPC)
xerava	TETRAPHASE PHARMACEUTICALS INC (TTPH)
XERAVA	Innoviva, Inc. (INVA)
XERAVA®	Innoviva, Inc. (INVA)
zerbaxa	Curative Biotechnology Inc (CUBT)

Phase 3(2)

Drug	Company
eravacycline	TETRAPHASE PHARMACEUTICALS INC (TTPH)
iv eravacycline	TETRAPHASE PHARMACEUTICALS INC (TTPH)

Phase 2(1)

Drug	Company
eravacycline	ARS Pharmaceuticals, Inc. (SPRY)

BioSniper tracks 11 drugs in development for Complicated Intra-abdominal Infection across 8 companies.

There are 1 clinical trial targeting Complicated Intra-abdominal Infection tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.